CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

inactivated covid-19 vaccine

Vaccineexperimental

Clinical trial activity

50 trials · 44 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
29
Phase 3
13
Phase 4
12

Earliest trial started Apr 25, 2021 (NCT04866069)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • SARS-CoV-2Immunity, active

    SARS-CoV-2 immunity, active

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06654973N/AAug 27, 2024A*Star, Duke University, Nanyang Technological University, National Center for Infectious Diseases
NCT06259578Early Phase 1 (Phase 1)Jan 29, 2024Airlangga University, Biotis Pharmaceuticals, Indonesia, Dr. Soetomo General Hospital, Government of Indonesia
NCT06997653Phase 2Jan 1, 2024Government of Turkey
NCT06272253Early Phase 1 (Phase 1)Sep 19, 2023Airlangga University, Biotis Pharmaceuticals, Indonesia, Dr. Soetomo General Hospital, Government of Indonesia
NCT06113731Phase 2Jul 10, 2023China National Biotec Group Co., Ltd, Government of China
NCT06282692Phase 3Jun 19, 2023Airlangga University, Biotis Pharmaceuticals, Indonesia, Dr. Soetomo General Hospital, Government of Indonesia
NCT05254236Phase 2Mar 10, 2023Gleneagles CRC, Sinovac Biotech Co., Ltd
NCT06113744Phase 1Mar 10, 2023China National Biotec Group Co., Ltd, Government of China, Hangzhou Hospital of Traditional Chinese Medicine
NCT05686161Phase 3Oct 19, 2022Government of Cambodia, Stemirna Therapeutics
NCT05696067Phase 1/Phase 2 (Phase 2)Sep 13, 2022Pavlov First Saint Petersburg State Medical University, Research Institute of Influenza, Russia
NCT05918939Early Phase 1 (Phase 1)Sep 5, 2022Airlangga University, Biotis Pharmaceuticals, Indonesia, Dr. Soetomo General Hospital, Government of Indonesia
NCT05574985N/AAug 29, 2022Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Bengbu Medical College
NCT05433272Phase 3Aug 10, 2022China National Pharmaceutical Group, Sinovac Biotech Co., Ltd
NCT06381843N/AAug 2, 2022Government of China, Sichuan University
NCT05465902Phase 2Jul 31, 2022Government of China
NCT05463354Phase 2Jul 7, 2022Government of China
NCT05508477Phase 3Jun 28, 2022Airlangga University, Biotis Pharmaceuticals, Indonesia, Dr. Soetomo General Hospital, Government of Indonesia
NCT05411471Phase 2Jun 8, 2022Gleneagles CRC, Sinovac Biotech Co., Ltd
NCT05323435Phase 2/Phase 3 (Phase 3)May 30, 2022AI Kuwait Hospital, Jiangsu Rec-Biotechnology Co., Ltd.
NCT05382871Phase 3May 27, 2022Beijing Tiantan Bio Co., Ltd, China National Biotec Group Co., Ltd, The University of Hong Kong, Wuhan Institute of Biological Products Co., Ltd
Showing 20 of 50 trials
Page 1 / 3

Organizations

Research & Development (44)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment18552021
China National Biotec Group Co., LtdFor profit10842021
Sinovac Biotech Co., LtdFor profit101032021
Airlangga UniversityAcademic/Hospital6032022
Beijing Tiantan Bio Co., LtdFor profit6022021
Biotis Pharmaceuticals, IndonesiaFor profit6032022
Dr. Soetomo General HospitalAcademic/Hospital6632022
Government of IndonesiaGovernment6032022
Government of TurkeyGovernment6522021
Sinocelltech Ltd.For profit4422022
China National Pharmaceutical GroupFor profit3222021
Wuhan Institute of Biological Products Co., LtdGovernment3022021
Gleneagles CRCAcademic/Hospital2012022
Aga Khan UniversityAcademic/Hospital1112022
AI Kuwait HospitalAcademic/Hospital1012022
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.For profit1112022
A*StarGovernment1012024
Bengbu Medical CollegeAcademic/Hospital1012022
Butantan InstituteAcademic/Hospital1012022
Chughtai LabAcademic/Hospital1012022
44 organizations
Page 1 / 3